Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban-Reference-Cited by-同舟云学术

Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban

Published:2020-07-24 Issue: Volume:7 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Martins Gabriela Lopes,Duarte Rita Carolina Figueiredo,Vieira Érica Leandro Marciano,Rocha Natalia Pessoa,Figueiredo Estêvão Lanna,Silveira Francisco Rezende,Caiaffa José Raymundo Sollero,Lanna Rodrigo Pinheiro,Carvalho Maria das Graças,Palotás András,Ferreira Cláudia Natália,Reis Helton José

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study;Chugh;Circulation.,2014

2. Impact of atrial fibrillation on the risk of death: the Framingham heart study;Benjamin;Circulation.,1998

3. Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry;Bassand;Circulation.,2019

4. Hospital and clinical care costs associated with atrial fibrillation for medicare beneficiaries in the cardiovascular health study and the Framingham heart study;Delaney;SAGE Open Med.,2018

5. 2019 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society;January;J Am Coll Cardiol.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

2. Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings;Biomolecules;2024-08-07

3. Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?;International Journal of Cardiology;2024-02

4. Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study;International Journal of Cardiology;2024-01

5. Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection;American Journal of Cardiovascular Drugs;2023-12-24